Materials And Products Tenders

Open House Discount Agreements 2024-04 - Rivaroxaban

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open...

Open House Discount Contracts 2024-05

Open Framework Agreement on Drug Discounts in Accordance with Section 130A Paragraph 8 Sgb V with the Possibility of Joining at any Time, So-Called Approval Model 2024-03

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for Various Active Ingredients/Combinations with the Possibility of Conclusion at any Time as Part of...

Open Framework Agreement on Drug Discounts in Accordance with Section 130A Paragraph 8 Sentence 1 Sgb V with the Possibility of Joining at any Time, So-Called Approval Model 2024-03

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Follitropin Alfa (Atc Code: G03ga05).

Drug Contracts with an Option to Join

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Fampridine (Atc Code: N07xx07).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Palonosetron (Atc Code: A04aa05).